Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPLEX FOR TREATING OPTIC NERVE DISEASE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/194109
Kind Code:
A1
Abstract:
Disclosed is a complex tFNA-miR22 for treating optic nerve disease, which complex is composed of tetrahedral DNA and miR-22 according to a molar ratio of 1: (1-4). The tFNA-miR22 can effectively inhibit apoptosis of retinal ganglion cells and promote the release of a brain-derived neurotrophic factor (BDNF), thereby achieving a good protection effect for the retinal ganglion cells. The tFNA-miR22 is used for preparing optic nerve protection drugs, the treatment of neurodegenerative optic nerve diseases including glaucoma is facilitated, and the tFNA-miR22 has very good application prospects.

Inventors:
LIN YUNFENG (CN)
LI JIAJIE (CN)
CAI XIAOXIAO (CN)
Application Number:
PCT/CN2022/080771
Publication Date:
September 22, 2022
Filing Date:
March 14, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHENGDU GENREZE GENE TECH CO LTD (CN)
International Classes:
A61K31/711; A61K31/7105; A61P25/02; A61P27/06
Domestic Patent References:
WO2013070821A12013-05-16
WO2018226640A12018-12-13
Foreign References:
CN112007044A2020-12-01
CN109072189A2018-12-21
CN109806275A2019-05-28
CN112007044A2020-12-01
Other References:
ZIZHONG HU; XUEHUA LV; LU CHEN; XUNYI GU; HUIMING QIAN; SILVIA FRANSISCA; ZHENGYU ZHANG; QINGHUAI LIU; PING XIE: "Protective effects of microRNA‐22‐3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome", JOURNAL OF CELLULAR PHYSIOLOGY, WILEY SUBSCRIPTION SERVICES, INC., US, vol. 234, no. 10, 29 March 2019 (2019-03-29), US , pages 18849 - 18857, XP071323532, ISSN: 0021-9541, DOI: 10.1002/jcp.28523
ZHENG QIJUN: "Nlrp1 Induces the Death of Retinal Ganglion Cells in Mice Sterile Optic Nerve Crush Injury", MEDICINE & PUBLIC HEALTH, CHINA DOCTORAL DISSERTATIONS FULL-TEXT DATABASE (ELECTRONIC JOURNALS), 15 March 2020 (2020-03-15), XP055966988
MOU LIN, LAI LI; YAN LI: "Correlation Between NLRP3 Inflammation Complex and the Degree of Optic Nerve Injury in Primary Glaucoma", GUOJI YANKE ZAZHI = INTERNATIONAL JOURNAL OF OPHTHALMOLOGY / INTERNATIONAL EYE SCIENCE, ZHONGHUA YIXUEHUI, XIAN FENHUI,, CN, vol. 19, no. 7, 31 July 2019 (2019-07-31), CN , pages 1123 - 1125, XP055966983, ISSN: 1672-5123, DOI: 10.3980/j.issn.1672-5123.2019.7.08
ZHANG, TAO ET AL.: "Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment", NATURE PROTOCOLS, vol. 15, no. 8, 15 July 2020 (2020-07-15), XP037207395, DOI: 10.1038/s41596-020-0355-z
ANDERS BJORKLUND AND ANGELA CENCI-NILSSON: "Event-Related Dynamics of Brain Oscillations", vol. 220, 1 January 2015, ELSEVIER, AMSTERDAM , NL , ISBN: 978-0-444-52183-5, ISSN: 0079-6123, article ROMANO GIOVANNI, PLATANIA CHIARA BIANCA MARIA, FORTE STEFANO, SALOMONE SALVATORE, DRAGO FILIPPO, BUCOLO CLAUDIO, BAGETTA GIACINTO: "Chapter 11: MicroRNA target prediction in glaucoma", pages: 217 - 240, XP009539960, DOI: 10.1016/bs.pbr.2015.04.013
ROMANO GLPLATANIA CBFORTE SSALOMONE SDRAGO FBUCOLO C: "MicroRNA target prediction in glaucoma", PROG BRAIN RES, vol. 220, 2015, pages 217 - 40, XP009539960, DOI: 10.1016/bs.pbr.2015.04.013
Attorney, Agent or Firm:
LECOME INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF: